FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2953153609> ?p ?o ?g. }

• W2953153609 endingPage "e0200664" @default.
• W2953153609 startingPage "e0200664" @default.
• W2953153609 abstract "Because human epidermal growth factor-like receptor (HER) 2 is expressed on the surface of human pancreatic carcinoma cells to varying degrees, trastuzumab, an anti-HER2 monoclonal antibody (mAb), is expected to exert antibody-dependent, natural killer (NK) cell-mediated cytotoxicity (ADCC) against the cells. However, some reports found that the effect of trastuzumab against human pancreatic carcinoma cells was limited because most express only limited HER2. We examined whether anti-CD137 stimulating mAb could enhance trastuzumab-mediated ADCC against Panc-1, a human pancreatic cancer cell line with low HER2 expression, in vitro. Supplementation of anti-CD137 mAb could improve trastuzumab-mediated ADCC against Panc-1 which was insufficient without this stimulating antibody. The ADCC differed in individual cells, and this was related to the expression of CD137 on the surface of NK cells after trastuzumab stimulation in association with the Fcγ-RIIIA polymorphism. NK cells with Fcγ-RIIIA-VV/VF showed high levels of ADCC against Panc-1, but those with Fcγ-RIIIA-FF did not show optimal ADCC. In addition, trastuzumab-mediated ADCC against the human pancreatic cancer cell line Capan-1 with high HER2 expression was generally high and not affected by the Fcγ-RIIIA polymorphism. These results demonstrated that in Fcγ-RIIIA-VV/VF-carrying healthy individuals, trastuzumab plus αCD137 mAb could induce effective ADCC against HER2-low-expressing pancreatic cancer cell lines, and that such an approach may result in similar findings in patients with pancreatic cancer." @default.
• W2953153609 created "2019-06-27" @default.
• W2953153609 creator A5000519458 @default.
• W2953153609 creator A5003538619 @default.
• W2953153609 creator A5011657050 @default.
• W2953153609 creator A5015404124 @default.
• W2953153609 creator A5025067812 @default.
• W2953153609 creator A5028015338 @default.
• W2953153609 creator A5039999047 @default.
• W2953153609 creator A5040132448 @default.
• W2953153609 creator A5051824895 @default.
• W2953153609 creator A5057582686 @default.
• W2953153609 creator A5058841198 @default.
• W2953153609 creator A5062104407 @default.
• W2953153609 creator A5080709934 @default.
• W2953153609 date "2018-12-31" @default.
• W2953153609 modified "2023-10-18" @default.
• W2953153609 title "Anti-CD137 monoclonal antibody enhances trastuzumab-induced, natural killer cell-mediated cytotoxicity against pancreatic cancer cell lines with low human epidermal growth factor-like receptor 2 expression" @default.
• W2953153609 cites W1541202145 @default.
• W2953153609 cites W1586153330 @default.
• W2953153609 cites W1854502346 @default.
• W2953153609 cites W1970264918 @default.
• W2953153609 cites W1974922522 @default.
• W2953153609 cites W1984510765 @default.
• W2953153609 cites W1990542020 @default.
• W2953153609 cites W1998414899 @default.
• W2953153609 cites W2011435623 @default.
• W2953153609 cites W2020074441 @default.
• W2953153609 cites W2033296826 @default.
• W2953153609 cites W2040935952 @default.
• W2953153609 cites W2045982658 @default.
• W2953153609 cites W2046136288 @default.
• W2953153609 cites W2049522382 @default.
• W2953153609 cites W2066471812 @default.
• W2953153609 cites W2066477716 @default.
• W2953153609 cites W2078454159 @default.
• W2953153609 cites W2090039904 @default.
• W2953153609 cites W2090712779 @default.
• W2953153609 cites W2098394317 @default.
• W2953153609 cites W2100439220 @default.
• W2953153609 cites W2104239861 @default.
• W2953153609 cites W2117563256 @default.
• W2953153609 cites W2122080125 @default.
• W2953153609 cites W2122584026 @default.
• W2953153609 cites W2122781730 @default.
• W2953153609 cites W2123228158 @default.
• W2953153609 cites W2123646476 @default.
• W2953153609 cites W2125615454 @default.
• W2953153609 cites W2133105825 @default.
• W2953153609 cites W2142287133 @default.
• W2953153609 cites W2143953275 @default.
• W2953153609 cites W2146384083 @default.
• W2953153609 cites W2147609992 @default.
• W2953153609 cites W2151253787 @default.
• W2953153609 cites W2151605875 @default.
• W2953153609 cites W2153565541 @default.
• W2953153609 cites W2158134441 @default.
• W2953153609 cites W2165480504 @default.
• W2953153609 cites W2166471103 @default.
• W2953153609 cites W2168109319 @default.
• W2953153609 cites W2170103621 @default.
• W2953153609 cites W2177971463 @default.
• W2953153609 cites W2288995881 @default.
• W2953153609 cites W2318605753 @default.
• W2953153609 cites W4211208840 @default.
• W2953153609 cites W75939749 @default.
• W2953153609 doi "https://doi.org/10.1371/journal.pone.0200664" @default.
• W2953153609 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6312288" @default.
• W2953153609 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30596643" @default.
• W2953153609 hasPublicationYear "2018" @default.
• W2953153609 type Work @default.
• W2953153609 sameAs 2953153609 @default.
• W2953153609 citedByCount "11" @default.
• W2953153609 countsByYear W29531536092020 @default.
• W2953153609 countsByYear W29531536092021 @default.
• W2953153609 countsByYear W29531536092022 @default.
• W2953153609 countsByYear W29531536092023 @default.
• W2953153609 crossrefType "journal-article" @default.
• W2953153609 hasAuthorship W2953153609A5000519458 @default.
• W2953153609 hasAuthorship W2953153609A5003538619 @default.
• W2953153609 hasAuthorship W2953153609A5011657050 @default.
• W2953153609 hasAuthorship W2953153609A5015404124 @default.
• W2953153609 hasAuthorship W2953153609A5025067812 @default.
• W2953153609 hasAuthorship W2953153609A5028015338 @default.
• W2953153609 hasAuthorship W2953153609A5039999047 @default.
• W2953153609 hasAuthorship W2953153609A5040132448 @default.
• W2953153609 hasAuthorship W2953153609A5051824895 @default.
• W2953153609 hasAuthorship W2953153609A5057582686 @default.
• W2953153609 hasAuthorship W2953153609A5058841198 @default.
• W2953153609 hasAuthorship W2953153609A5062104407 @default.
• W2953153609 hasAuthorship W2953153609A5080709934 @default.
• W2953153609 hasBestOaLocation W29531536091 @default.
• W2953153609 hasConcept C121608353 @default.
• W2953153609 hasConcept C126322002 @default.
• W2953153609 hasConcept C153911025 @default.
• W2953153609 hasConcept C159654299 @default.
• W2953153609 hasConcept C203014093 @default.
• W2953153609 hasConcept C2779786085 @default.

• next